Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

Abstract Background This analysis evaluates the cost-effectiveness of insulin degludec (degludec) versus biosimilar insulin glargine U100 (glargine U100) in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) in Bulgaria. Methods A simple, short-term model was used to compare the treatme...

Full description

Bibliographic Details
Main Authors: Monika Russel-Szymczyk, Vasil Valov, Alexandra Savova, Manoela Manova
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Endocrine Disorders
Subjects:
Cost-effectiveness
Diabetes
Hypoglycaemia
ICER
Insulin degludec
QALY
Online Access:https://doi.org/10.1186/s12902-019-0460-6

Internet

https://doi.org/10.1186/s12902-019-0460-6

Similar Items